Prenatal Repeat Corticosteroids In Women At Risk Of Preterm Birth For Improving Neonatal Health - An Individual Patient Data Review
Funder
National Health and Medical Research Council
Funding Amount
$461,063.00
Summary
Giving repeat doses of prenatal corticosteroids to women at high risk of preterm birth reduces the risk of their babies having serivous health problems in the early weeks of life. It is unclear what dose, number of doses and interval between doses of corticosteroids is optimal. This review will determine if and how individual women should be treated with repeat corticosteroids to improve the health of their baby born too soon.
The Benefits And Harms Associated With Breast Cancer Screening In The Australian Context.
Funder
National Health and Medical Research Council
Funding Amount
$80,222.00
Summary
Australia is caught in a dilemma. Breast screening is well-established however there has been fierce debate about the value of screening programmes. I will determine the frequency of benefit and harm due to breast screening programs in Australia to better understand the true extent of overdiagnosis and overtreatment. Based on this information, I will make recommendations about how breast screening should be provided in Australia in future and clearly communicate this information to the community
Improving Antiretroviral Treatment (ART) Initiation For People Living With HIV In Australia: A Realistic And Feasible Approach?
Funder
National Health and Medical Research Council
Funding Amount
$434,722.00
Summary
Antiretroviral treatment (ART) has improved the lives of people living with HIV (PLHIV). This study will investigate barriers, incentives and reasons that influence decision making of PLHIV and clinicians regarding whether to start ART and when. The study will examine the potential public health impact of promoting ART use on the HIV epidemic. The study will make significant contributions to improvement of ART use and advances in HIV prevention.
Evidence-based Recommendations For Interpregnancy Intervals In High-income Countries
Funder
National Health and Medical Research Council
Funding Amount
$423,305.00
Summary
This study will identify the optimal and harmful interpregnancy intervals for a range of maternal and child outcomes in three high-income countries. With a study population of more than 7.5 million births and a longitudinal study design that matches pregnancies to the same women, this study will inform new interpregnancy interval recommendations for high-income countries that will lead to a reduction in avoidable excess morbidities attributable to uninformed pregnancy planning.
Defining An Ethical And Evidence-based Approach To Clinical Research In Children And Adolescents With Chronic Kidney Disease (CKD)
Funder
National Health and Medical Research Council
Funding Amount
$84,800.00
Summary
Chronic kidney disease (CKD) in children and adolescents is a serious health condition, which impacts patients' academic abilities and achievement as well as their social wellbeing and their physical and mental health. This study will investigate the range of impacts that CKD has on patients and families, and explore the ways that these problems should best be addressed in future research from the perspective of patients and their families.
The Clinical Burden Of Campylobacter Infection In Australia
Funder
National Health and Medical Research Council
Funding Amount
$99,448.00
Summary
Campylobacter is a leading but less well recognised cause of gastroenteritis in Australia. This research seeks to better quantify and describe serious health outcomes resulting from Campylobacter infections by examining hospitalisations (including risk factors for admission) and estimating rates of death and long-term health problems following infection. The project will also examine the role GPs play in managing cases, particularly their use of antibiotics.
HIV Treatment As Prevention: A Longitudinal Assessment Of Population Effectiveness
Funder
National Health and Medical Research Council
Funding Amount
$783,160.00
Summary
This project is a large-scale evaluation of an HIV strategy known as ‘treatment as prevention’ (TasP). Through routine and repeat HIV testing for gay men and early treatment initiation following diagnosis, TasP aims to reduce HIV community infection rates. Through the establishment of a large cohort of gay men in NSW and Victoria, this study will track HIV testing, treatment and management to assess the real-world efficacy of TasP for reducing HIV infections among this at-risk population.
Improving Global Tuberculosis Control With The AuTuMN Platform
Funder
National Health and Medical Research Council
Funding Amount
$655,059.00
Summary
Tuberculosis (TB) is the world’s leading infectious killer, with the failure of global control responsible for the vast majority of Australia’s cases. Using our robustly developed software platform, we have performed several country-level studies to predict the future burden of disease and compare the impact of alternative responses to controlling the epidemic. In this project, we will extend our platform to perform simulations at the global level and answer key questions in TB control.